MedPath

Shoes for adolescent kneecap pain: the SHAPE randomised clinical trial

Not Applicable
Recruiting
Conditions
Patellofemoral pain
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12623000042640
Lead Sponsor
The University of Melbourne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
158
Inclusion Criteria

i)adolescents aged 12 to 19 years,
ii)participate in planned sport and exercise-based activities that load the patellofemoral joint for at least 60 minutes per week,
iii)participate in planned sport and exercise-based activities that load the patellofemoral joint and that cause knee pain either during or after that is greater than or equal to 3 on an 11-point numerical rating scale (0 no pain; 10 = worst pain imaginable),
iv)report pain in or around the front of the knee that is aggravated by at least one activity that loads the patellofemoral joint during weightbearing, including squatting, stair climbing, running, hopping, jumping,
v)have a history of knee pain for greater than or equal to 2 months.

Exclusion Criteria

i)attending primary school,
ii)a history of patellar dislocation,
iii)traumatic onset of knee symptoms,
iv)recent knee surgery in the past 6 months or planned surgery in next 3 months,
v)unable to wear study footwear during sport and exercise activities,
vi)current use of shoe orthoses,
vii)diagnosed in the past 12 months by a health professional as having a knee condition other than patellofemoral pain,
viii)self-report other muscle or joint condition anywhere in the body which is worse than study knee pain,
ix)self-report any systemic or inflammatory joint disease (e.g., juvenile idiopathic arthritis),
x)any neurological condition affecting the spine or either lower limb, and
xi)inability to understand written/spoken English.
xii)unable to commit to study requirements (eg wearing shoes, attending appointments, completing outcomes, do not have foot size in the range of 7 to 13 US for men, and 6 to 11US for women).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath